Annual EBITDA
-$51.96 M
-$14.24 M-37.75%
December 1, 2023
Summary
- As of February 22, 2025, BCAX annual EBITDA is -$51.96 million, with the most recent change of -$14.24 million (-37.75%) on December 1, 2023.
- During the last 3 years, BCAX annual EBITDA has fallen by -$14.24 million (-37.75%).
- BCAX annual EBITDA is now -37.75% below its all-time high of -$37.72 million, reached on December 1, 2022.
Performance
BCAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$20.61 M
NaN%
September 30, 2024
Summary
- As of February 22, 2025, BCAX quarterly EBITDA is -$20.61 million
- Over the past year, BCAX quarterly EBITDA has dropped by -$11.09 million (-116.34%).
- BCAX quarterly EBITDA is now -116.34% below its all-time high of -$9.53 million, reached on September 30, 2023.
Performance
BCAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$20.61 M
NaN%
September 30, 2024
Summary
- As of February 22, 2025, BCAX TTM EBITDA is -$20.61 million
- Over the past year, BCAX TTM EBITDA has dropped by -$11.09 million (-116.34%).
- BCAX TTM EBITDA is now -116.34% below its all-time high of -$9.53 million, reached on September 30, 2023.
Performance
BCAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BCAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.8% | -116.3% | -116.3% |
| 3 y3 years | -37.8% | -116.3% | -116.3% |
| 5 y5 years | -37.8% | -116.3% | -116.3% |
BCAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.8% | at low | -116.3% | at low | -116.3% | at low |
| 5 y | 5-year | -37.8% | at low | -116.3% | at low | -116.3% | at low |
| alltime | all time | -37.8% | at low | -116.3% | at low | -116.3% | at low |
Bicara Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.61 M(+116.3%) | -$20.61 M(+116.3%) |
| Dec 2023 | -$51.96 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$9.53 M | -$9.53 M |
| Dec 2022 | -$37.72 M | - | - |
FAQ
- What is Bicara Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Bicara Therapeutics?
- What is Bicara Therapeutics annual EBITDA year-on-year change?
- What is Bicara Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly EBITDA year-on-year change?
- What is Bicara Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Bicara Therapeutics?
- What is Bicara Therapeutics TTM EBITDA year-on-year change?
What is Bicara Therapeutics annual EBITDA?
The current annual EBITDA of BCAX is -$51.96 M
What is the all time high annual EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high annual EBITDA is -$37.72 M
What is Bicara Therapeutics annual EBITDA year-on-year change?
Over the past year, BCAX annual EBITDA has changed by -$14.24 M (-37.75%)
What is Bicara Therapeutics quarterly EBITDA?
The current quarterly EBITDA of BCAX is -$20.61 M
What is the all time high quarterly EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly EBITDA is -$9.53 M
What is Bicara Therapeutics quarterly EBITDA year-on-year change?
Over the past year, BCAX quarterly EBITDA has changed by -$11.09 M (-116.34%)
What is Bicara Therapeutics TTM EBITDA?
The current TTM EBITDA of BCAX is -$20.61 M
What is the all time high TTM EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM EBITDA is -$9.53 M
What is Bicara Therapeutics TTM EBITDA year-on-year change?
Over the past year, BCAX TTM EBITDA has changed by -$11.09 M (-116.34%)